Loading…
CCM market intelligence says Chinese amino acid makers are shifting toward minor amino acids such as valine, isoleucine and glutamine for healthcare and pharma uses, which earn higher margins than bulk products like glycine and taurine. Feed still accounts for the largest share of the market due to demand from poultry and livestock.
CCM warns that continued capacity expansion could lead to oversupply, adding pressure from environmental rules.
Overcapacity in Chinese amino acids could push down prices of feed-grade amino acids such as lysine and methionine, benefiting feed compounders, while environmental curbs could tighten supply and reverse that effect.
nutraingredients.comGary ScattergoodOct 17, 2017Not enough comparable past events yet for a historical read.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
